Fondazione Irccs Istituto Nazionale Dei Tumori, Milano

This study looks at 100 women aged 18-45 with early-stage uterine cancer who want to preserve fertility. Researchers will test tumor genetics to see if different molecular subtypes respond differently to hormone therapy. The goal is to better predict who will have a complete resp…